Display options
Cite
Widschwendter M, Dubeau L. Non-Surgical Cancer Risk Reduction in . Cancers (Basel). 2020;12(3)doi: 10.3390/cancers12030547.
Widschwendter, M., & Dubeau, L. (2020). Non-Surgical Cancer Risk Reduction in . Cancers, 12(3), . https://doi.org/10.3390/cancers12030547
Widschwendter, Martin, and Dubeau, Louis. "Non-Surgical Cancer Risk Reduction in ." Cancers vol. 12,3 (2020). doi: https://doi.org/10.3390/cancers12030547
Widschwendter M, Dubeau L. Non-Surgical Cancer Risk Reduction in . Cancers (Basel). 2020 Feb 27;12(3). doi: 10.3390/cancers12030547. PMID: 32120796; PMCID: PMC7139938.
Copy Download .nbib Format: NLM
Share it on

Cancers (Basel). 2020 Feb 27;12(3). doi: 10.3390/cancers12030547.

Non-Surgical Cancer Risk Reduction in .

Cancers

Martin Widschwendter, Louis Dubeau

Affiliations

  1. Department of Women's Cancer, University College London, 74 Huntley Street, London WC1E 6AU, UK.
  2. Research Institute for Biomedical Aging Research, Universität Innsbruck, 6020 Innsbruck, Austria.
  3. European Translational Oncology Prevention and Screening (EUTOPS) Institute, 6060 Hall in Tirol, Austria.
  4. Department of Pathology, Keck School of Medicine, USC/Norris Comprehensive Cancer Centre, University of Southern California, Los Angeles, CA 90089, USA.

PMID: 32120796 PMCID: PMC7139938 DOI: 10.3390/cancers12030547

Abstract

Women-specific cancers are a major health issue, particularly those associated with the

Keywords: BRCA1 mutations; breast cancer; ovarian cancer; prevention

Conflict of interest statement

The authors declare no conflicts of interest.

References

  1. Nat Med. 2016 Aug;22(8):933-9 - PubMed
  2. Fertil Steril. 2004 Jul;82(1):186-95 - PubMed
  3. Nat Genet. 2017 May;49(5):680-691 - PubMed
  4. Curr Biol. 2005 Mar 29;15(6):561-5 - PubMed
  5. Int J Cancer. 2012 Jun 1;130(11):2495-504 - PubMed
  6. Lancet Oncol. 2008 Dec;9(12):1191-7 - PubMed
  7. Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):601-10 - PubMed
  8. Br J Cancer. 1981 Jan;43(1):72-6 - PubMed
  9. J Sex Res. 2018 Nov-Dec;55(9):1087-1095 - PubMed
  10. Nature. 2010 Nov 4;468(7320):98-102 - PubMed
  11. Nat Genet. 2007 Feb;39(2):157-8 - PubMed
  12. Lab Invest. 2012 Jun;92(6):802-11 - PubMed
  13. Cancer Res. 2010 Jan 1;70(1):221-8 - PubMed
  14. J Pathol. 2007 Jan;211(1):26-35 - PubMed
  15. J Natl Cancer Inst. 2014 Jun 28;106(7): - PubMed
  16. BMC Cancer. 2019 Aug 14;19(1):807 - PubMed
  17. Am J Reprod Immunol. 2018 Feb;79(2): - PubMed
  18. Nat Rev Clin Oncol. 2018 May;15(5):292-309 - PubMed
  19. Int J Cancer. 2018 Dec 1;143(11):2932-2942 - PubMed
  20. Am J Epidemiol. 1992 Nov 15;136(10):1184-203 - PubMed
  21. Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):755-64 - PubMed
  22. JNCI Cancer Spectr. 2018 Jun 28;2(2):pky023 - PubMed
  23. J Natl Cancer Inst. 2014 Feb;106(2):djt431 - PubMed
  24. Lancet Oncol. 2015 Jan;16(1):67-75 - PubMed
  25. Genome Biol. 2016 Oct 3;17(1):205 - PubMed
  26. N Engl J Med. 1998 Aug 13;339(7):424-8 - PubMed
  27. Genome Med. 2014 Jun 27;6(6):47 - PubMed
  28. J Clin Oncol. 2015 Apr 20;33(12):1397-406 - PubMed
  29. Nat Commun. 2016 May 24;7:11620 - PubMed
  30. J Chronic Dis. 1987;40 Suppl 2:59S-69S - PubMed
  31. Bull Exp Biol Med. 2018 Dec;166(2):222-224 - PubMed
  32. Lancet Oncol. 2019 Aug;20(8):1171-1182 - PubMed
  33. Lancet. 2014 Mar 22;383(9922):1041-8 - PubMed
  34. EBioMedicine. 2015 Sep 09;2(10):1331-9 - PubMed
  35. PLoS One. 2015 Oct 21;10(10):e0139013 - PubMed
  36. Lancet Oncol. 2013 Nov;14(12):1226-32 - PubMed
  37. Radiology. 2015 Jun;275(3):675-82 - PubMed

Publication Types

Grant support